ARHGEF37 and hepatocellular carcinoma: In terms of the specific mechanism, ARHGEF37 directly interacts with and activates Cdc42 to promote the formation of invasive pseudopods within HCC cells, thereby disrupting the interaction between endothelial cells and pericytes.